期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
静脉输注利多卡因在无痛结肠镜检查中的临床应用 被引量:3
1
作者 毛珊珊 张晗 +2 位作者 高航 郑孝振 陈勇 《中国内镜杂志》 2021年第6期43-48,共6页
目的观察静脉输注利多卡因在无痛结肠镜检查中的临床效果,探讨其有效性和安全性。方法选择在该院接受无痛结肠镜检查的患者90例,采用随机数字表法分为3组:舒芬太尼复合丙泊酚组(S组)、利多卡因复合丙泊酚组(L组)和单纯丙泊酚组(P组),每... 目的观察静脉输注利多卡因在无痛结肠镜检查中的临床效果,探讨其有效性和安全性。方法选择在该院接受无痛结肠镜检查的患者90例,采用随机数字表法分为3组:舒芬太尼复合丙泊酚组(S组)、利多卡因复合丙泊酚组(L组)和单纯丙泊酚组(P组),每组30例。采用双盲法分别给予每组患者相应药物,持续监测并记录给药前(T_(0))、睫毛反射消失时(T_(1))、过脾曲时(T_(2))、过肝曲时(T_(3))以及镜检完成时(T_(4))的心率(HR)、平均动脉压(MAP)和脉搏血氧饱和度(SpO_(2)),观察3组患者术中丙泊酚预给量、追加量、总用量、不良事件发生情况和术后恢复情况等。结果与T0时点相比,3组患者T_(1)~T_(4)时点MAP、HR均明显降低(P<0.05),与T_(1)时点相比,P组T_(2)~T_(4)时点MAP、HR明显升高(P<0.05),3组SpO_(2)差异无统计学意义(P>0.05);S组和L组丙泊酚预给量、追加量和总用量均明显少于P组(P<0.05);L组苏醒时间明显短于S组和P组(P<0.05);术后腹部疼痛视觉模拟评分(VAS)和虚弱VAS评分L组明显优于S组或P组(P<0.05);L组注射痛、恶心呕吐、低氧血症发生率明显优于S组或P组(P<0.05),3组患者术中高血压、低血压、心动过缓发生率差异无统计学意义(P>0.05)。结论静脉输注利多卡因应用于无痛结肠镜检查中,可有效降低丙泊酚用量、稳定血流动力学、减少不良反应发生,加快术后恢复。 展开更多
关键词 静脉输注利多因 丙泊酚 舒芬太尼 无痛结肠镜
下载PDF
Protective effect of methylprednisolone combined with ulinastatin pretreatment on inflammatory lung injury induced by anesthesia for esophageal cancer 被引量:1
2
作者 Di-Xin Wang Xian-Feng Xie +2 位作者 Rong-Juan Jiang Hui-Ling Cao xiao-zhen zheng 《Journal of Hainan Medical University》 2019年第12期62-66,共5页
Objective:To investigate the protective effect of methylprednisolone combined with ulinastatin pretreatment on inflammatory lung injury induced by single-lung ventilation.Methods: A total of 120 patients with radical ... Objective:To investigate the protective effect of methylprednisolone combined with ulinastatin pretreatment on inflammatory lung injury induced by single-lung ventilation.Methods: A total of 120 patients with radical resection of cancer surgery admitted to our hospital from January 2016 to December 2017 were randomly divided into control group, methylprednisolone group, ulinastatin group, and methylprednisolone combined with ulinastatin pretreatment group. Before single lung ventilation (T0), 30 min after ventilation (T1), and 60 min (T2) after the end of ventilation, enzyme-linked immunosorbent kit method was used to detect the levels of inflammatory factors TNF-α, IL-8 and IL-10. The mean airway pressure (Pmean) at each monitoring point and the oxygenation indexes (PaO2/FiO2) before and after surgery were detected. And also, the extraction time, drainage volume and sputum volume of the drainage tube after surgery were measured.Results:Compared with the control group, the other three groups can reduce the levels of TNF-α and IL-8 in the blood of patients with esophageal cancer, improve IL-10 and increase the oxygenation index (P<0.05). However, methylprednisolone combined with ulinastatin pretreatment group was significantly better than methylprednisolone group and ulinastatin group in reducing serum inflammatory factor levels and increasing oxygenation index. In addition, the drainage tube extraction time, drainage volume and sputum volume of the patients treated with methylprednisolone combined with ulinastatin were also significantly lower than those of the control group, the methylprednisolone group and the ulinastatin group.Conclusions: Methylprednisolone combined with ulinastatin has a synergistic protective effect on inflammatory lung injury caused by radical resection of esophageal cancer patients, which is worthy of first-line clinical recommendation. 展开更多
关键词 Inflammatory lung injury Sou-Medrol ULINASTATIN Surgery for ESOPHAGEAL cancer ANESTHESIA
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部